Rockwell Medical (RMTI) Change in Receivables (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Change in Receivables came in at $682000.0 in Q1 2026, down 50.54% YoY from $1.4 million in Q1 2025, and up 1018.03% on a QoQ basis from $61000.0 in Q4 2025.
Rockwell Medical (RMTI) Change in Receivables (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Change in Receivables data on file, last reported at $682000.0 in Q1 2026.
- Quarterly Change in Receivables fell 50.54% year-over-year to $682000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$599000.0 (up 57.94% YoY) and the FY2025 annual result came in at $98000.0, up 103.75% from the prior year.
- Change in Receivables grew to $682000.0 in Q1 2026, from $61000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $4.0 million in Q3 2023 to a low of -$2.0 million in Q3 2024.
- A 5-year average of $185764.7 and a median of $61000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables plunged 800.81% — and 2023, when it jumped 646.33%.
- Tracing RMTI's Change in Receivables over 5 years: stood at -$1.1 million in 2022, then soared by 238.99% to $1.5 million in 2023, then slumped by 138.05% to -$586000.0 in 2024, then jumped by 110.41% to $61000.0 in 2025, then jumped by 1018.03% to $682000.0 in 2026.
- The last three Change in Receivables figures came in at $682000.0 (Q1 2026), $61000.0 (Q4 2025), and $244000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | -970,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -970,000.00 |
| Jun 30, 2026 | -970,000.00 |
| Mar 31, 2026 | 682,000.00 |
| Mar 31, 2026 | 682,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Jun 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -586,000.00 |
| Dec 31, 2024 | -586,000.00 |
| Sep 30, 2024 | -1.96 Mn |
| Sep 30, 2024 | -1.96 Mn |
| Jun 30, 2024 | -254,000.00 |
| Jun 30, 2024 | -254,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |